BTG3 and autoimmune disease: The median age of patients both in the comparison group and in most of the study group, which is well above the age at which we might expect occurrence of systemic autoimmune diseases [28], might be explained by the tendency to refer patients to ANA diagnostics even in the absence of clear symptoms of autoimmune diseases, but rather in cases of otherwise unexplained symptoms and uncertain diagnoses.